Cipla has been among the major players in the Indian pharmaceutical industry for many years. Cipla has earned its name through confidence, affordability of medications, and has a solid presence in India and around the world. Now let’s take an in-depth glance at Cipla Net worth, owner, CEO, Head Office information.
| Company | Cipla Limited |
| Founder | Khwaja Abdul Hamied |
| Current Chairperson | Y. K. Hamied (Chairperson) |
| CEO | Umang Vohra |
| Headquarters | Mumbai |
| Year of establishment | 1935 |
| Industry | Pharmaceutical |
| Net income(2025) | Rs 5,273 crore |
| Total assets | Rs37,387 crore |
Company Profile
Cipla was established to 1935 Mumbai. The company’s early days concentrated on the most essential medications that could be purchased by the average person. This strategy helped build Cipla’s reputation.Today, Cipla manufactures medicines in the areas of respiratory, anti-HIV/AIDS diabetes care, cardiac care, and other segments.You’ll also see Cipla’s footprint now spread across over 80 nations.
Despite being a huge multinational corporation, Cipla still maintains the image of a health brand, which aims to make the medicine available to all.
Net Worth (Market Cap)
According to recent data on financials Cipla’s market cap is at
Its revenue is 1.21 trillion. The total assets of the company is the sum of Rs 37,387 crore.This indicates how solid and steady the company is in the Indian as well as the global market for pharmaceuticals.
Head Office
Cipla’s main office is within Mumbai, Maharashtra.
Future Outlook
If we think about Cipla’s future, Cipla its direction, it’s quite obvious. Cipla is investing more energy into areas like the treatment of respiratory diseases, biotech products and the most advanced generics.And there is a constant demand for these products not only in India but across other countries as well. Cipla is also focusing to boost their research and development in order that new medications can be available to patients faster. The principle is simple, make sure the prices are reasonable and the quality high and be reliable.It is expanding in a consistent, deliberate approach, with a focus on the things that matter most in healthcare.